[HTML][HTML] Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
RF Butterworth - Frontiers in Neuroscience, 2023 - frontiersin.org
Advent of the acute respiratory coronavirus SARS-CoV-2 has resulted in the search for novel
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
[HTML][HTML] Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
RF Butterworth - Frontiers in Neuroscience, 2023 - frontiersin.org
Advent of the acute respiratory coronavirus SARS-CoV-2 has resulted in the search for novel
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
[HTML][HTML] Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
RF Butterworth - Frontiers in Neuroscience, 2023 - ncbi.nlm.nih.gov
Advent of the acute respiratory coronavirus SARS-CoV-2 has resulted in the search for novel
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
RF Butterworth - Frontiers in neuroscience, 2023 - pubmed.ncbi.nlm.nih.gov
Advent of the acute respiratory coronavirus SARS-CoV-2 has resulted in the search for novel
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
Frontiers in Neuroscience, 2023 - europepmc.org
Advent of the acute respiratory coronavirus SARS-CoV-2 has resulted in the search for novel
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2.
RF Butterworth - Frontiers in Neuroscience, 2023 - search.ebscohost.com
Advent of the acute respiratory coronavirus SARS-CoV-2 has resulted in the search for novel
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
antiviral agents and in the repurposing of existing agents with demonstrated efficacy against …
[PDF][PDF] Adamantanes for the treatment of neurodegenerative diseases in the presence of SARS-CoV-2
RF Butterworth - 2023 - scienceopen.com
Neurodegenerative diseases including Parkinson's disease [PD], Alzheimer's disease [AD],
and Multiple sclerosis [MS] are increasingly considered to represent comorbidities in …
and Multiple sclerosis [MS] are increasingly considered to represent comorbidities in …